Kristopher A. Lofgren
- Co-authors
- Carol A. LangeAndrea R. DanielJulie H. OstranderCelina G. KleerParaic A. KennyAmanda JiangMathumai KanapathipillaiElaine P.S. Gee
- Topics
- HER2/EGFR in Cancer Research (6 papers)Lung Cancer Treatments and Mutations (4 papers)Cancer Diagnosis and Treatment (3 papers)
- Partner nations
- United StatesSwitzerlandCzechia
In The Last Decade
Kristopher A. Lofgren
18 papers receiving 450 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 278
- Oncology 198
- Cancer Research 88
- Pulmonary and Respiratory Medicine 77
- Cell Biology 52
Countries citing papers authored by Kristopher A. Lofgren
This map shows the geographic impact of Kristopher A. Lofgren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristopher A. Lofgren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristopher A. Lofgren more than expected).
Fields of papers citing papers by Kristopher A. Lofgren
This network shows the impact of papers produced by Kristopher A. Lofgren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristopher A. Lofgren. The network helps show where Kristopher A. Lofgren may publish in the future.
Co-authorship network of co-authors of Kristopher A. Lofgren
This figure shows the co-authorship network connecting the top 25 collaborators of Kristopher A. Lofgren. A scholar is included among the top collaborators of Kristopher A. Lofgren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristopher A. Lofgren. Kristopher A. Lofgren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 9 | |
| 5 | 11 | |
| 6 | 4 | |
| 7 | 2 | |
| 8 | 0 | |
| 9 | 24 | |
| 10 | 0 | |
| 11 | 5 | |
| 12 | 5 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 41 | |
| 16 | 48 | |
| 17 | 110 | |
| 18 | 28 | |
| 19 | 42 | |
| 20 | 113 |
About Kristopher A. Lofgren
Kristopher A. Lofgren is a scholar working on Oncology, Cancer Research and Hepatology, having authored 20 papers that have together received 451 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (198 citations), Immunology and Allergy (36 citations) and Cancer Research (88 citations). Kristopher A. Lofgren has collaborated with scholars based in United States, Switzerland and Czechia. Frequent co-authors include Carol A. Lange, Andrea R. Daniel, Julie H. Ostrander, Celina G. Kleer, Paraic A. Kenny, Amanda Jiang, Mathumai Kanapathipillai, Elaine P.S. Gee, Akiko Mammoto and Tadanori Mammoto. Their work appears in journals such as Nature Communications, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.